Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$775K Sell
10,275
-822
-7% -$58.6K ﹤0.01% 1443
2025
Q4
$685K Buy
11,097
+1,290
+13% +$75.9K ﹤0.01% 1446
2025
Q3
$574K Buy
9,807
+603
+7% +$35.1K ﹤0.01% 1372
2025
Q2
$540K Buy
9,204
+2,636
+40% +$149K ﹤0.01% 1315
2025
Q1
$329K Buy
6,568
+951
+17% +$48.7K ﹤0.01% 1358
2024
Q4
$263K Buy
+5,617
New +$267K ﹤0.01% 1404

Other funds holding NTR

&Partners's NTR Position: Q1 2026 in Review

&Partners reduced its Nutrien (NTR) stake by 7.4% in Q1 2026, selling an estimated $58.6K and leaving 10,275 shares worth $775K. The position accounts for ﹤0.01% of the portfolio, ranked #1443.

&Partners first reported a position in NTR in Q4 2024 and has held it in 6 quarters since. 747 funds tracked by Wall St. Rank hold NTR as of Q1 2026.

  • &Partners held 10,275 shares of Nutrien worth $775K as of Q1 2026.
  • &Partners sold 822 Nutrien shares in Q1 2026, an estimated $58.6K.
  • Nutrien made up ﹤0.01% of &Partners's portfolio in Q1 2026, its #1443 holding.
  • &Partners first reported a position in Nutrien in Q4 2024 and has held it in 6 quarters since.
  • 747 funds tracked by Wall St. Rank held Nutrien as of Q1 2026.

Based on &Partners's 13F filing for Q1 2026, filed 15 May 2026.